MacroGenics
MGNX
#8434
Rank
HK$2.14 B
Marketcap
HK$33.68
Share price
-5.40%
Change (1 day)
191.86%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2026 (TTM): -HK$11.98

According to MacroGenics's latest financial reports the company's current EPS (TTM) is -HK$12.00. In 2025 the company made an earnings per share (EPS) of -HK$9.25 a decrease over its 2024 EPS that were of -HK$8.39.

EPS history for MacroGenics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$11.9829.44%
2025-HK$9.2510.28%
2024-HK$8.39613.33%
2023-HK$1.18-92.31%
2022-HK$15.29-42.14%
2021-HK$26.4236.44%
2020-HK$19.37-21.84%
2019-HK$24.78-24.58%
2018-HK$32.85675.93%
2017-HK$4.23-68.05%
2016-HK$13.25168.25%
2015-HK$4.94-55%
2014-HK$10.983400%
2013-HK$0.31-108.68%
2012HK$3.6124.49%
2011HK$2.90

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$10.27-185.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$221.32-1,944.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$113.54-1,046.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$58.18-584.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$28.03-333.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$27.91-332.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-HK$17.96 49.67%๐Ÿ‡บ๐Ÿ‡ธ USA